Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout
Clinical trial NCT05925166 · COMPLETED
Trial details
- NCT number
- NCT05925166
- Sponsor
- Lihua Duan
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2025-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.